BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34370842)

  • 1. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
    Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
    Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune deficiency and risk for malignancy among persons with AIDS.
    Mbulaiteye SM; Biggar RJ; Goedert JJ; Engels EA
    J Acquir Immune Defic Syndr; 2003 Apr; 32(5):527-33. PubMed ID: 12679705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
    Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
    J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015.
    Poizot-Martin I; Lions C; Cheret A; Rey D; Duvivier C; Jacomet C; Allavena C; Huleux T; Bani-Sadr F; Obry-Roguet V; Makinson A;
    AIDS; 2020 Mar; 34(4):569-577. PubMed ID: 31764070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.
    Yanik EL; Achenbach CJ; Gopal S; Coghill AE; Cole SR; Eron JJ; Moore RD; Mathews WC; Drozd DR; Hamdan A; Ballestas ME; Engels EA
    J Clin Oncol; 2016 Sep; 34(27):3276-83. PubMed ID: 27507879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.
    Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
    Clin Infect Dis; 2016 Nov; 63(10):1373-1379. PubMed ID: 27535953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.
    Jaffe HW; De Stavola BL; Carpenter LM; Porter K; Cox DR;
    AIDS; 2011 Jul; 25(11):1395-403. PubMed ID: 21572307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.
    ; Bohlius J; Schmidlin K; Costagliola D; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Karafoulidou A; Miro JM; Lundgren J; Chene G; Egger M
    Antivir Ther; 2009; 14(8):1065-74. PubMed ID: 20032536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.
    Castilho JL; Bian A; Jenkins CA; Shepherd BE; Sigel K; Gill MJ; Kitahata MM; Silverberg MJ; Mayor AM; Coburn SB; Wiley D; Achenbach CJ; Marconi VC; Bosch RJ; Horberg MA; Rabkin CS; Napravnik S; Novak RM; Mathews WC; Thorne JE; Sun J; Althoff KN; Moore RD; Sterling TR; Sudenga SL;
    J Natl Cancer Inst; 2022 Jun; 114(6):854-862. PubMed ID: 35292820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
    Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA;
    J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
    Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
    J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
    ; Rohner E; Schmidlin K; Zwahlen M; Chakraborty R; Clifford G; Obel N; Grabar S; Verbon A; Noguera-Julian A; Collins IJ; Rojo P; Brockmeyer N; Campbell M; Chêne G; Prozesky H; Eley B; Stefan DC; Davidson A; Chimbetete C; Sawry S; Davies MA; Kariminia A; Vibol U; Sohn A; Egger M; Bohlius J
    Clin Infect Dis; 2016 Nov; 63(9):1245-1253. PubMed ID: 27578823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.
    Achenbach CJ; Buchanan AL; Cole SR; Hou L; Mugavero MJ; Crane HM; Moore RD; Haubrich RH; Gopal S; Eron JJ; Hunt PW; Rodriguez B; Mayer K; Saag MS; Kitahata MM;
    Clin Infect Dis; 2014 Jun; 58(11):1599-606. PubMed ID: 24523217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
    Mukhtar F; Ilozumba M; Utuama O; Cimenler O
    JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.
    AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord
    Clin Infect Dis; 2017 Oct; 65(8):1316-1326. PubMed ID: 28531260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi.
    Gopal S; Liomba NG; Montgomery ND; Moses A; Kaimila B; Nyasosela R; Chikasema M; Dhungel BM; Kampani C; Sanders MK; Krysiak R; Dittmer DP; Fedoriw Y
    J Int AIDS Soc; 2015; 18(1):20122. PubMed ID: 26242311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma.
    Tam HK; Zhang ZF; Jacobson LP; Margolick JB; Chmiel JS; Rinaldo C; Detels R
    Int J Cancer; 2002 Apr; 98(6):916-22. PubMed ID: 11948473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
    Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
    Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.